» Articles » PMID: 31776323

Integrative Analysis of Expression Profiles of MicroRNAs and MRNAs in Treatment of Acute Myocardial Infarction with Compound Longmaining Decoction

Overview
Journal Med Sci Monit
Date 2019 Nov 29
PMID 31776323
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND This study identified microRNAs (miRNAs) and mRNAs associated with Compound Longmaining (CLMN) treatment of acute myocardial infarction (AMI). Our results provide a theoretical framework to guide AMI treatment and improve myocardial injury. MATERIAL AND METHODS The myocardial tissues of the sham operation group (S), the model group (M), and the CLMN treatment group (T) were obtained. The mRNA and miRNA expression profiles were identified using RNA-sequencing analysis. The sequencing results were verified by quantitative real-time PCR (qRT-PCR). Bioinformatics was used to predict the function of differentially expressed genes (DEGs) and related signal transduction pathways. The target genes of miRNAs were predicted by software analysis, and the relationship between miRNA and mRNA was studied by network analysis. RESULTS RNA-sequencing revealed 22 differentially expressed miRNAs (DEMs) and 76 DEGs in myocardial tissue. Six DEMs and 9 DEGs were randomly selected for qRT-PCR validation, and corroborating results were obtained. The results of Gene ontology (GO) showed that DEGs participated in different biological processes. Through the combined analysis of miRNAs and mRNAs expression, it was confirmed that a single miRNA is involved in the regulation of multiple genes, and also multiple miRNAs can target one gene. CONCLUSIONS The analysis based on the miRNA-mRNA network can not only help to elucidate the potential molecular mechanism of CLMN treatment of AMI, but can also help in identifying novel therapeutic targets.

Citing Articles

Fungal protein D1 inhibits the proliferation of A549 cells via activating the p53/miR-34a signaling pathway.

Zhang M, Liu F, Gao W, Liu Z J Nat Med. 2025; .

PMID: 39966243 DOI: 10.1007/s11418-024-01869-0.


Exosomal miR-218-5p/miR-363-3p from Endothelial Progenitor Cells Ameliorate Myocardial Infarction by Targeting the p53/JMY Signaling Pathway.

Ke X, Yang R, Wu F, Wang X, Liang J, Hu X Oxid Med Cell Longev. 2021; 2021:5529430.

PMID: 34326916 PMC: 8302385. DOI: 10.1155/2021/5529430.

References
1.
Ganesan J, Ramanujam D, Sassi Y, Ahles A, Jentzsch C, Werfel S . MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors. Circulation. 2013; 127(21):2097-106. DOI: 10.1161/CIRCULATIONAHA.112.000882. View

2.
Fang J, Song X, Tian J, Chen H, Li D, Wang J . Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis. 2011; 17(4):410-23. DOI: 10.1007/s10495-011-0683-0. View

3.
Passino C, Barison A, Vergaro G, Gabutti A, Borrelli C, Emdin M . Markers of fibrosis, inflammation, and remodeling pathways in heart failure. Clin Chim Acta. 2014; 443:29-38. DOI: 10.1016/j.cca.2014.09.006. View

4.
Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B . Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res. 2008; 18(8):823-33. DOI: 10.1038/cr.2008.81. View

5.
Zhang X, Lu Z, Liu L . Coronary heart disease in China. Heart. 2008; 94(9):1126-31. DOI: 10.1136/hrt.2007.132423. View